Ragwitek Pregnancy Warnings
Animal reproduction studies have not been performed. There are no controlled data in human pregnancy.
This drug should be used during pregnancy only if clearly needed.
US FDA pregnancy category: C
US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
See references
